Valeant Pharmaceuticals reported $425M in Pre-Tax Profit for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amgen AMGN:US $ 2727M 56M
Biogen BIIB:US $ 903.4M 316.6M
Bristol Myers Squibb BMY:US $ 5386M 595M
Canopy Growth Corp WEED:CN C$ -587071000 471.39M
Catalent CTLT:US $ 251M 37M
Danaher DHR:US $ 2561.71M 44.71M
JAZZ PHA JAZZ:US $ 321.29M 19.04M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Pacira Pharmaceuticals PCRX:US $ 39.79M 19.7M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Supernus Pharmaceuticals SUPN:US $ 14.72M 12.67M
Zoetis ZTS:US $ 769M 188M